Skip to main content

An Investigation of Plasma Collection, Stabilization, and Storage Procedures for Proteomic Analysis of Clinical Samples

Hulmes JD, Bethea D, Ho K, Huang S, Ricci DL, Opitek GJ, Hefta SA

Publication: Clin Proteom (2001) • Vol 1 • Page 17-31

Purpose

The purpose of this paper was to assess the potential influence of the following processing variables on plasma proteomic analyses: storage duration and temperature, type of anticoagulant, presence of protease inhibitors, and freeze-thaw cycling.

Conclusion

The stability of the plasma proteome was not significantly affected by storage of specimens at 4 degrees C for (a) 4-6 hours prior to centrifugation or (b) for 48 hours after separation when protease inhibitors were used; however, storage of centrifuged non-separated specimens at 4 degrees C for 48 hours elicited results that differed significantly from immediately processed controls, as did exclusion of protease inhibitors in immediately processed specimens. Freeze-thaw cycling (up to 2 cycles), frozen storage at -20 degrees C, and anticoagulant type did not induce significant alterations to the plasma proteome.

Studies (1)

Purpose

The purpose of this study was to assess the potential influence of the following processing variables on plasma proteomic analyses: storage duration and temperature, type of anticoagulant, presence of protease inhibitors, and freeze-thaw cycling.

Summary of Findings

Two-dimensional gel electrophoretic analysis revealed that refrigeration of blood specimens at 4 degrees C for 4-6 hours before centrifugation or after plasma separation did not significantly affect results, nor did frozen storage at -20 degrees C or 2 freeze-thaw cycles. However, storage of centrifuged non-separated specimens at 4 degrees C for 48 hours, or exclusion of protease inhibitors, resulted in significant derivations from controls processed and frozen immediately. Immunoassays for Placental Cadherin (PCAD) and soluble Vascular Adhesion Molecule-1 (sVCAM-1) similarly displayed significantly higher levels in specimens lacking protease inhibitors compared to controls.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
  • Platforms

    Protein1D/2D gels
    ProteinImmunoassay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    EDTA
    Lithium heparin
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    StorageFreeze/thaw cycling
    1 cycle
    2 cycles
    StorageStorage duration
    4-6 h
    48 h
    StorageStorage temperature
    -20 degrees C
    -70 degrees C
    4 degrees C
    Analyte Extraction and PurificationProtease inhibitor
    Cocktail